Professor of Biostatistics and Clinical Trials, Queen Mary University of London
Rhian studied her MPhil in Epidemiology in 1998-1999. She stayed on at the Institute of Public Health for a short time afterwards working with Carol Brayne on the CC75C study, before joining the then newly formed MRC Clinical Trials Unit, London as a statistician.
Her subsequent career progression and research is summarised on here.
The MPhil in Epidemiology in Cambridge was a turning point in my career. I started out with some practical experience from having worked in a trials office, but the MPhil taught me methods and research skills I would come to use later in my career. I felt very lucky to have been taught by some of the most experienced and respected researchers in the field on the MPhil. I was inspired and motivated to hear about their work and learn from them. I made some good friends on the course. The choice of topics being taught and small group size for practical work provided me with a broad base of knowledge and confidence in my research. I was particularly interested in cancer research and trials, and these have been abiding interests throughout my career. One of our essays was a review about a controversial topic of our choosing. I chose breast cancer screening in women in their 40’s and found it fascinating. A few years later I returned to the topic of breast cancer screening for my PhD, and have since been lucky enough to have worked on some really exciting trials in the areas of prostate cancer detection (PROMIS – using MRI) and lung cancer screening (YLST – using low dose CT). The MPhil provided me with excellent foundations that have helped in my research.
Dr Kelly Bolton, MD PhD
Medical Oncology Fellow at Memorial Sloan Kettering
Dr. Bolton attended medical school at UCLA School of Medicine and completed a residency in Internal Medicine at Weill-Cornell Medical College-NYP. She has a MPhil in Epidemiology and a PhD in Genetic Epidemiology from the University of Cambridge. Dr. Bolton’s research focuses on the use of blood-based genomic screens for early detection of malignancies and pre-malignant states.
My time at Cambridge as an MPhil student was the most intellectually enriching (and fun) part of my education. The small class sizes, one-on-one interactions with world-class epidemiologists and research thesis gave me a really strong background in epidemiologic theory and application. Because of the small class sizes I developed strong relationships with many of my course mates and we continue to remain in touch and collaborate to this day. After seven years, I continue to remain in contact with several MPhil faculty who still mentor me to this day. Comparing my experience at Cambridge to my American colleagues’ experience in their graduate epidemiology courses I would definitely say that I received much more individual attention and feedback. Graduate life at Cambridge is also very unique compared to the States with much more social activities and interest groups specifically for graduate students. Cambridge, and the Department of Epidemiology and Public health is a very special place and the MPhil was truly a once-in-a-lifetime experience for me.
Dr David Wormser
Real World Data Science Manager
Roche, Basel, Switzerland
Dr Wormser completed his MPhil in Epidemiology in 2008. Subsequently, David enrolled in a 3-year PhD program at the Cardiovascular Epidemiology Unit (CEU), Department of Public Health and Primary Care in Cambridge. Under the supervision of Dr Angela Wood and Professor John Danesh, David’s research focused on the association of adiposity markers and risk of cardiovascular disease using large-scale observational data from the Emerging Risk Factors Collaboration (ERFC). His work was published in the Lancet in 2011.
After completion of his PhD in 2011, David continued with his research at the CEU as a post-doc. In 2014, he accepted a global position as an Epidemiologist at Roche, UK. Currently, David is leading a Global Real World Data group in neuroscience and rare diseases.
David said: “The education received at Cambridge provided me with all the necessary skills and tools to conduct observational studies to support the research, development and access of new drugs at Roche”
Dr Miriam S. Udler, MD PhD
Endocrinologist, Massachusetts General Hospital
The University of Cambridge MPhil in Epidemiology was a truly fantastic learning experience! The course offered high quality teaching in principles of epidemiology that laid the foundation for the research I have performed ever since. Additionally, the hands on research experience leading to the masters thesis helped solidify the concepts presented in lectures and provided an opportunity for performing cutting-edge research with world-class research mentors. I would highly recommend this course! For me it was truly life-changing, as it paved the way for my future career in genetic epidemiology research and introduced me to exceptional colleagues and mentors.
Following the MPhil, I went on to complete an MD/PhD, followed by residency in Internal Medicine and fellowship in Endocrinology. I am now an Endocrinologist at Massachusetts General Hospital (MGH), where I focus clinically on genetic forms of endocrine conditions as the director of the Diabetes Genetics Clinic. I also continue to perform research at MGH and the Broad Institute of MIT and Harvard with a focus on the genetics of type 2 diabetes.